Total Artificial Heart

The Devices
Heart Assist Pump
Artificial Heart
Clinical Trial
History
PSU Heart News
Teaching, Research, Service
Teaching
Research
Service

Press Information

Penn State
Artificial Heart Researchers
To Work With Abiomed, Inc.
Artificial Heart
The Penn State completely implantable total electric artificial heart is being developed in cooperation with ABIOMED, Inc., Danvers, Mass.
The Penn State Heart is designed to replace a patient's irreversibly failing heart. It is implanted, along with a controller and energy transmission system, in the space left by removal of the patient's heart. Once the system is implanted in the patient, no wires, tubes or other connections protrude through the skin.
The Penn State Heart, the result of nearly 30 years of research, is one of the most successful devices to emerge from a program supported by the U.S. National Heart, Lung and Blood Institutes. The device is expected to enter clinical trials in about two years.

PENN STATE -- HERSHEY MEDICAL CENTER |Contact us: aem1@psu.edu for information on Penn State Research
A'ndrea Messer for problems with this web site.

The Devices Heart Assist Pump Artificial Heart Clinical Trial History PSU Heart News Teaching, Research, Service Teaching Research Service Press Information
		Penn State Artificial Heart Researchers To Work With Abiomed, Inc. Artificial Heart The Penn State completely implantable total electric artificial heart is being developed in cooperation with ABIOMED, Inc., Danvers, Mass. The Penn State Heart is designed to replace a patient's irreversibly failing heart. It is implanted, along with a controller and energy transmission system, in the space left by removal of the patient's heart. Once the system is implanted in the patient, no wires, tubes or other connections protrude through the skin. The Penn State Heart, the result of nearly 30 years of research, is one of the most successful devices to emerge from a program supported by the U.S. National Heart, Lung and Blood Institutes. The device is expected to enter clinical trials in about two years.